Narrative Review : Update on Cardiogenic Shock and It's Management

Rahil Annisyah Putri D; Faisal Sommeng; Muhammad Asrul Apris; Nurhikmawati Nurhikmawati; Muh. Nur Abadi

Authors

Rahil Annisyah Putri D Program Studi Profesi Dokter Umum Fakultas Kedokteran Universitas Muslim Indonesia
Faisal Sommeng Bagian Ilmu Anestesiologi Fakultas Kedokteran Universitas Muslim Indonesia
Muhammad Asrul Apris Bagian Ilmu Penyakit Jantung dan Pembuluh Darah Fakultas Kedokteran Universitas Muslim Indonesia
Nurhikmawati Nurhikmawati Bagian Ilmu Penyakit Jantung dan Pembuluh Darah Fakultas Kedokteran Universitas Muslim Indonesia
Muh. Nur Abadi Bagian Ilmu Anestesiologi Fakultas Kedokteran Universitas Muslim Indonesia

Keywords:

Cardiogenic Shock, Acute Myocardial Infarction, STEMI

Abstract

Cardiogenic shock is a condition of tissue hypoperfusion caused by primary abnormalities in the heart where there is a decrease in cardiac output, resulting in circulatory failure which results in hypoperfusion and tissue hypoxia. The most common cause of cardiogenic shock is acute myocardial infarction (AMI), of which 70% show a picture of ST-Elevation infarction (STEMI). The Society for Cardiovascular Angiography and Interventions (SCAI) has established five classifications of cardiogenic shock, namely A (At Risk), B (Beginning), C (Classic), D (Deteriorating), and E (Extreme). The main treatment that can be carried out in patients with cardiogenic shock is stabilizing the patient's oxygenation and circulation, then treating the underlying etiology of cardiogenic shock.

References

Blumer V, Kanwar MK, Barnett CF, Cowger JA, Damluji AA, Farr M, et al. Cardiogenic Shock in Older Adults: A Focus on Age-Associated Risks and Approach to Management: A Scientific Statement From the American Heart Association. Circulation. 2024;

Kosaraju A, Pendela V, Hai O. Cardiogenic Shock. Treasure Isl StatPearls. 2023; Available from: https://www.ncbi.nlm.nih.gov/books/NBK482255/

Bagaswoto HP, Juzar DA, Habib F, Bramantyo YS, Sanggula PNPP, Widiastuti AZ. Cardiogenic Shock. Indones J Cardiol. 2023;42(3):90–9.

Laghlam D, Benghanem S, Ortuno S, Bouabdallaoui N, Manzo-Silberman S, Hamzaoui O, et al. Management of cardiogenic shock: a narrative review. Ann Intensive Care. 2024;14(1). Available from: https://doi.org/10.1186/s13613-024-01260-y

Samsky MD, Morrow DA, Proudfoot AG, Hochman JS, Thiele H, Rao S V. Cardiogenic Shock after Acute Myocardial Infarction: A Review. JAMA - J Am Med Assoc. 2021;326(18):1840–50.

Bonello L, Laine M, Puymirat E, Ceccaldi V, Gaubert M, Paganelli F, et al. Etiology and Prognosis of Cardiogenic Shock in a Secondary Center without Surgical Back-Up. Cardiol Res Pract. 2019;2019(Lv).

Sciaccaluga C, Mandoli GE, Ghionzoli N, Anselmi F, Dini CS, Righini F, et al. Risk Stratification in Cardiogenic Shock: a Focus on the Available Evidence. Heart Fail Rev. 2022;27(4):1105–17. Available from: https://doi.org/10.1007/s10741-021-10140-7

Squara P, Hollenberg S, Payen D. Reconsidering Vasopressors for Cardiogenic Shock: Everything Should Be Made as Simple as Possible, but Not Simpler. Chest. 2019;156(2):392–401. Available from: https://doi.org/10.1016/j.chest.2019.03.020

Vahdatpour C, Collins D, Goldberg S. Cardiogenic Shock. J Am Heart Assoc. 2019;8(8):1–12.

Baran DA, Grines CL, Bailey S, Burkhoff D, Hall SA, Henry TD, et al. SCAI Clinical Expert Consensus Statement on The Classification of Cardiogenic Shock. Catheter Cardiovasc Interv. 2019;94(1):29–37.

Reyentovich A, Barghash MH, Hochman JS. Management of Refractory Cardiogenic Shock. Nat Rev Cardiol. 2016;13(8):481–92. Available from: http://dx.doi.org/10.1038/nrcardio.2016.96

Levy B, Klein T, Kimmoun A. Vasopressor use in cardiogenic shock. Curr Opin Crit Care. 2020;26(4):411–6.

Fuernau G, Beck J, Desch S, Eitel I, Jung C, Erbs S, et al. Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction: Randomized SHOCK-COOL Trial. Circulation. 2019;139(4):448–57.

Mebazaa A, Combes A, van Diepen S, Hollinger A, Katz JN, Landoni G, et al. Management of cardiogenic shock complicating myocardial infarction. Intensive Care Med. 2018;44(6):760–73. Available from: https://doi.org/10.1007/s00134-018-5214-9

Tewelde SZ, Liu SS, Winters ME. Cardiogenic Shock. Cardiol Clin. 2018;36(1):53–61. Available from: https://doi.org/10.1016/j.ccl.2017.08.009

Saxena A, Garan AR, Kapur NK, O’Neill WW, Lindenfeld J, Pinney SP, et al. Value of Hemodynamic Monitoring in Patients with Cardiogenic Shock Undergoing Mechanical Circulatory Support. Circulation. 2020;141(14):1184–97.

Chioncel O, Parissis J, Mebazaa A, Thiele H, Desch S, Bauersachs J, et al. Epidemiology, pathophysiology and contemporary management of cardiogenic shock – a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020;22(8):1315–41.

Van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, et al. Contemporary Management of Cardiogenic Shock: A Scientific Statement from the American Heart Association. Vol. 136, Circulation. 2017. 232–268 p.

de Asua I, Rosenberg A. On the right side of the heart: Medical and mechanical support of the failing right ventricle. J Intensive Care Soc. 2017;18(2):113–20.

L.C. P, S.J. W, S.J. F, P.S. M, S.J. B. Pulmonary vascular and right ventricular dysfunction in adult critical care: Current and emerging options for management: A systematic literature review. Crit Care. 2010;14(5). Available from: http://ccforum.com/content/14/5/R169%5Cnhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed9&NEWS=N&AN=2011024738

Goyal A, Daneshpajouhnejad P, Hashmi MF, Bashir K. Acute Kidney Injury. NCBI Bookshelf. 2024; Available from: https://www.ncbi.nlm.nih.gov/books/NBK441896/